Renal Sympathectomy in dialysis-dependent patients to reduce cardiovascular risk. A pilot study
- Conditions
- End Stage Kidney DiseaseRenal and Urogenital - Kidney diseaseCardiovascular - Other cardiovascular diseasesCardiovascular - Hypertension
- Registration Number
- ACTRN12613000562774
- Lead Sponsor
- niversity of Otago
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 15
Age > 18 and able to give consent.
On dialysis for at least 3 months.
Clinically stable with no evidence of fluid overload, recent myocardial ischaemia or heart attack.
Blood pressure > 130/90 despite medications.
They must have intact native renal kidneys
Patients with significant renovascular abnormalities will not permitted to undergo the intervention. Anatomic abnormalities including multiple main renal arteries, short length main renal arteries, failed renal transplant, are exclusion criteria.
Inability to give consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in renal sympathetic nerve activity as measured by multiunit sympathetic nerve activity[Baseline prior to the procedure, then at 1month, 3 months and 12 months after the procedure]
- Secondary Outcome Measures
Name Time Method Changes in cardiac function as assessed by beat to beat variability on holter monitoring, echocardiographic changes in left ventricular function and volume, and changes in blood pressure.[Baseline prior to the procedure and then at 1 month, 3 months, 12 months after the procedure]; Changes in circulating plasma catecholamines and beat to beat variability in heart rate as markers of systemic sympathetic activity after the intervention compared to baseline values.[Baseline prior to the procedure and at 1 month. 3 months, 12 months after the procedure.]